Pharmaceutical Executive March 16, 2020
Jill Wechsler

Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus. Political infighting has stymied an effective response in the US, with much finger-pointing on all sides. As the severity of the disease becomes more starkly apparent, schools and communities have shut down and cancellations have hit most travel, sports, and business and professional meetings.

An efficient effort by the US health care system to identify and isolate infected individuals has been undermined by a lack of fast and available diagnostics, and remedies have been derailed by political missteps and administrative failings. Short supplies of test kits and of reagents have forced clinics and hospitals...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Provider, Supply Chain, Technology, Trends
How Healthcare Revolutionaries Think: 10 Questions with Kemena Brooks
Avoidable deaths dropped worldwide – but not in the US
Podcast: How Healthcare Revolutionaries Think With Kemena Brooks
Measles Defense 101: The Significance of Employee Immunization Tracking
As Measles Outbreak Spikes, NIH Drastically Cuts Funding On Vaccine Hesitancy

Share This Article